PE/TR Anti-Human CD47 Antibody[CC2C6D4]

Introducing the PE/TR Anti-Human CD47 Antibody [CC2C6D4], a cutting-edge product designed to revolutionize the field of immunology. This antibody, meticulously developed by our team of expert scientists, offers unparalleled specificity and efficacy in targeting the CD47 protein, a key regulator of immune responses.

The PE/TR Anti-Human CD47 Antibody [CC2C6D4] is meticulously engineered to ensure optimal performance and reliability. Its unique formulation guarantees exceptional binding affinity to the CD47 protein, enabling precise and accurate detection in various experimental settings. This antibody's exceptional specificity ensures minimal cross-reactivity, thereby enhancing the accuracy of experimental results.

With its dual labeling of PE and TR, this antibody provides researchers with the flexibility to choose the most suitable detection method for their specific experimental needs. The PE/TR labeling system offers enhanced sensitivity and compatibility with a wide range of flow cytometry platforms, facilitating seamless integration into existing laboratory workflows.

Moreover, the PE/TR Anti-Human CD47 Antibody [CC2C6D4] exhibits exceptional stability and consistency, ensuring reproducible results across multiple experiments. Its long shelf life and robust performance make it an ideal choice for both routine laboratory use and cutting-edge research applications.

In summary, the PE/TR Anti-Human CD47 Antibody [CC2C6D4] represents a breakthrough in immunological research, offering unmatched specificity, reliability, and versatility. With its exceptional performance and ease of use, this antibody is poised to revolutionize the study of CD47 protein and its role in immune regulation. Experience the future of immunology with the PE/TR Anti-Human CD47 Antibody [CC2C6D4].